• Home
  • Drivers of infliximab biosimilar uptake: A comparative analysis of new biosimilar initiations versus switching in a national rheumatology registry.

Drivers of infliximab biosimilar uptake: A comparative analysis of new biosimilar initiations versus switching in a national rheumatology registry.

Author List
Roberts ET, Bansback N, Tseng CW, Shiboski S, Li J, Schmajuk G, Yazdany J
Publication
Health services research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/567002350
Publication Year
2024
PubMed ID
39618177
Publication Title
Roberts ET, Bansback N, Tseng CW, Shiboski S, Li J, Schmajuk G, Yazdany J. Drivers of infliximab biosimilar uptake: A comparative analysis of new biosimilar initiations versus switching in a national rheumatology registry. Health Serv Res. 2024 Dec 01.